 Max Mitchell
Concepts (313)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypoplastic Left Heart Syndrome | 15 | 2021 | 109 | 3.990 |
Why?
| | Heart Defects, Congenital | 22 | 2022 | 671 | 3.980 |
Why?
| | Cardiac Surgical Procedures | 19 | 2022 | 414 | 3.890 |
Why?
| | Fontan Procedure | 15 | 2023 | 157 | 3.820 |
Why?
| | Tetralogy of Fallot | 6 | 2022 | 81 | 3.340 |
Why?
| | Hemodynamics | 16 | 2021 | 1012 | 2.930 |
Why?
| | Ventricular Dysfunction, Left | 10 | 2022 | 358 | 2.850 |
Why?
| | Aortic Diseases | 4 | 2020 | 106 | 2.520 |
Why?
| | Norwood Procedures | 5 | 2021 | 22 | 2.430 |
Why?
| | Ventricular Function, Left | 9 | 2023 | 467 | 2.280 |
Why?
| | Aorta | 10 | 2021 | 386 | 2.210 |
Why?
| | Heart Transplantation | 18 | 2023 | 665 | 2.210 |
Why?
| | Aorta, Thoracic | 9 | 2023 | 256 | 1.800 |
Why?
| | Postoperative Complications | 16 | 2020 | 2128 | 1.670 |
Why?
| | Heart Ventricles | 13 | 2023 | 712 | 1.510 |
Why?
| | Pulmonary Artery | 13 | 2022 | 1016 | 1.440 |
Why?
| | Vascular Stiffness | 6 | 2020 | 407 | 1.420 |
Why?
| | Vascular Surgical Procedures | 5 | 2019 | 259 | 1.410 |
Why?
| | Pulmonary Valve | 4 | 2019 | 89 | 1.250 |
Why?
| | Magnetic Resonance Imaging, Cine | 8 | 2023 | 172 | 1.050 |
Why?
| | Pulmonary Valve Stenosis | 2 | 2016 | 16 | 1.000 |
Why?
| | Abnormalities, Multiple | 2 | 2018 | 178 | 1.000 |
Why?
| | Ventricular Dysfunction, Right | 5 | 2022 | 217 | 0.960 |
Why?
| | Extracorporeal Membrane Oxygenation | 6 | 2021 | 241 | 0.960 |
Why?
| | Heart-Assist Devices | 7 | 2021 | 485 | 0.910 |
Why?
| | Treatment Outcome | 31 | 2022 | 9088 | 0.900 |
Why?
| | Child | 41 | 2023 | 18420 | 0.790 |
Why?
| | Jugular Veins | 2 | 2019 | 38 | 0.730 |
Why?
| | Humans | 93 | 2023 | 114705 | 0.730 |
Why?
| | Truncus Arteriosus | 1 | 2020 | 6 | 0.730 |
Why?
| | Retrospective Studies | 30 | 2023 | 12556 | 0.730 |
Why?
| | Thrombosis | 2 | 2021 | 298 | 0.720 |
Why?
| | Heart Valve Prosthesis Implantation | 3 | 2019 | 174 | 0.720 |
Why?
| | Infant, Newborn | 22 | 2023 | 5047 | 0.710 |
Why?
| | Child, Preschool | 26 | 2022 | 9118 | 0.710 |
Why?
| | Infant | 34 | 2023 | 7964 | 0.710 |
Why?
| | Aortic Aneurysm, Thoracic | 2 | 2020 | 122 | 0.700 |
Why?
| | Aortic Stenosis, Supravalvular | 2 | 2011 | 6 | 0.690 |
Why?
| | Heart Valve Prosthesis | 2 | 2019 | 121 | 0.690 |
Why?
| | Diverticulum | 1 | 2020 | 11 | 0.680 |
Why?
| | Cardiovascular Abnormalities | 1 | 2020 | 10 | 0.680 |
Why?
| | Subclavian Artery | 1 | 2020 | 29 | 0.670 |
Why?
| | Cardiomyopathies | 2 | 2021 | 298 | 0.660 |
Why?
| | Infant, Newborn, Diseases | 1 | 2020 | 104 | 0.640 |
Why?
| | Magnetic Resonance Imaging | 16 | 2023 | 3053 | 0.640 |
Why?
| | Bioprosthesis | 1 | 2019 | 36 | 0.630 |
Why?
| | Vena Cava, Superior | 2 | 2018 | 21 | 0.630 |
Why?
| | Heart Valve Diseases | 2 | 2019 | 161 | 0.600 |
Why?
| | Vena Cava, Inferior | 1 | 2018 | 56 | 0.590 |
Why?
| | Echocardiography | 6 | 2023 | 553 | 0.580 |
Why?
| | Vascular Malformations | 1 | 2018 | 47 | 0.580 |
Why?
| | Elastin | 2 | 2015 | 78 | 0.580 |
Why?
| | Heart Septal Defects, Ventricular | 2 | 2016 | 39 | 0.580 |
Why?
| | Computed Tomography Angiography | 3 | 2023 | 97 | 0.570 |
Why?
| | Ventricular Function, Right | 6 | 2022 | 250 | 0.560 |
Why?
| | Vascular Remodeling | 1 | 2018 | 153 | 0.550 |
Why?
| | Aortic Coarctation | 4 | 2023 | 70 | 0.550 |
Why?
| | Blood Flow Velocity | 6 | 2020 | 387 | 0.540 |
Why?
| | Adolescent | 27 | 2021 | 17853 | 0.530 |
Why?
| | Aortic Valve Stenosis | 3 | 2022 | 272 | 0.530 |
Why?
| | Ventricular Outflow Obstruction | 3 | 2022 | 38 | 0.520 |
Why?
| | Transposition of Great Vessels | 1 | 2016 | 29 | 0.510 |
Why?
| | Male | 48 | 2023 | 55607 | 0.500 |
Why?
| | Pulmonary Veno-Occlusive Disease | 1 | 2015 | 11 | 0.480 |
Why?
| | Pulmonary Circulation | 4 | 2019 | 407 | 0.480 |
Why?
| | Female | 47 | 2023 | 59521 | 0.480 |
Why?
| | Perfusion Imaging | 3 | 2019 | 51 | 0.470 |
Why?
| | Research Design | 1 | 2020 | 928 | 0.470 |
Why?
| | Regional Blood Flow | 3 | 2021 | 424 | 0.460 |
Why?
| | Pulmonary Valve Insufficiency | 3 | 2022 | 41 | 0.450 |
Why?
| | Time Factors | 14 | 2022 | 6116 | 0.450 |
Why?
| | Reoperation | 10 | 2016 | 514 | 0.430 |
Why?
| | Heart Failure | 4 | 2021 | 1945 | 0.420 |
Why?
| | Systole | 4 | 2022 | 171 | 0.420 |
Why?
| | Palliative Care | 7 | 2020 | 644 | 0.420 |
Why?
| | Graft Survival | 2 | 2012 | 446 | 0.390 |
Why?
| | Arterial Occlusive Diseases | 1 | 2012 | 74 | 0.390 |
Why?
| | Risk Factors | 12 | 2022 | 8632 | 0.390 |
Why?
| | Cardiopulmonary Bypass | 6 | 2020 | 178 | 0.370 |
Why?
| | Young Adult | 12 | 2020 | 10471 | 0.360 |
Why?
| | Coronary Stenosis | 1 | 2011 | 39 | 0.360 |
Why?
| | Follow-Up Studies | 9 | 2021 | 4411 | 0.350 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2012 | 181 | 0.340 |
Why?
| | Coronary Vessels | 2 | 2022 | 227 | 0.340 |
Why?
| | Myocardial Perfusion Imaging | 2 | 2020 | 34 | 0.340 |
Why?
| | Atrioventricular Block | 2 | 2022 | 37 | 0.340 |
Why?
| | Heart Diseases | 4 | 2023 | 331 | 0.330 |
Why?
| | Ventricular Remodeling | 3 | 2022 | 226 | 0.330 |
Why?
| | Graft Rejection | 3 | 2016 | 513 | 0.330 |
Why?
| | Treatment Failure | 5 | 2015 | 331 | 0.320 |
Why?
| | Endothelin-1 | 2 | 2022 | 168 | 0.320 |
Why?
| | Mitral Valve Stenosis | 1 | 2008 | 21 | 0.310 |
Why?
| | Biomechanical Phenomena | 2 | 2020 | 669 | 0.280 |
Why?
| | Trachea | 2 | 2021 | 224 | 0.280 |
Why?
| | Predictive Value of Tests | 5 | 2023 | 1796 | 0.270 |
Why?
| | Myocardial Contraction | 4 | 2020 | 313 | 0.270 |
Why?
| | Case-Control Studies | 7 | 2021 | 3003 | 0.270 |
Why?
| | Magnetic Resonance Angiography | 3 | 2020 | 220 | 0.260 |
Why?
| | Diastole | 3 | 2022 | 130 | 0.250 |
Why?
| | Aortic Valve | 6 | 2022 | 398 | 0.240 |
Why?
| | Coronary Circulation | 2 | 2022 | 133 | 0.240 |
Why?
| | Ventricular Dysfunction | 1 | 2004 | 16 | 0.240 |
Why?
| | Coronary Artery Disease | 1 | 2010 | 607 | 0.240 |
Why?
| | Marfan Syndrome | 2 | 2018 | 42 | 0.230 |
Why?
| | Electrocardiography | 3 | 2023 | 560 | 0.230 |
Why?
| | Matrix Metalloproteinase 8 | 1 | 2023 | 9 | 0.220 |
Why?
| | Stroke Volume | 3 | 2022 | 504 | 0.220 |
Why?
| | Survival Analysis | 5 | 2009 | 1211 | 0.200 |
Why?
| | Pulmonary Atresia | 1 | 2022 | 20 | 0.200 |
Why?
| | Stress, Mechanical | 3 | 2019 | 445 | 0.200 |
Why?
| | Cardiomyopathy, Dilated | 2 | 2019 | 348 | 0.200 |
Why?
| | Bronchial Diseases | 1 | 2002 | 38 | 0.200 |
Why?
| | Heart Bypass, Right | 1 | 2022 | 15 | 0.200 |
Why?
| | Vascular Diseases | 1 | 2004 | 230 | 0.190 |
Why?
| | Coronary Angiography | 2 | 2022 | 304 | 0.190 |
Why?
| | Replantation | 1 | 2021 | 33 | 0.190 |
Why?
| | Arrhythmias, Cardiac | 1 | 2023 | 279 | 0.180 |
Why?
| | Altitude | 2 | 2019 | 432 | 0.180 |
Why?
| | Tomography, X-Ray Computed | 2 | 2020 | 2286 | 0.180 |
Why?
| | Age Factors | 3 | 2019 | 2894 | 0.170 |
Why?
| | Surgical Wound Infection | 1 | 2022 | 248 | 0.170 |
Why?
| | Kynurenine | 1 | 2020 | 81 | 0.170 |
Why?
| | Heart Function Tests | 1 | 2019 | 58 | 0.170 |
Why?
| | Elective Surgical Procedures | 1 | 2020 | 151 | 0.170 |
Why?
| | Tryptophan | 1 | 2020 | 136 | 0.170 |
Why?
| | Prospective Studies | 8 | 2023 | 6220 | 0.160 |
Why?
| | Tissue and Organ Procurement | 1 | 2022 | 228 | 0.160 |
Why?
| | Hypertension, Pulmonary | 2 | 2021 | 1729 | 0.160 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2020 | 141 | 0.160 |
Why?
| | Troponin I | 1 | 2019 | 68 | 0.160 |
Why?
| | Mitral Valve | 3 | 2021 | 86 | 0.160 |
Why?
| | Kaplan-Meier Estimate | 3 | 2010 | 811 | 0.160 |
Why?
| | Interleukin-1 Receptor-Like 1 Protein | 1 | 2019 | 22 | 0.160 |
Why?
| | Models, Cardiovascular | 1 | 2020 | 178 | 0.160 |
Why?
| | Dilatation, Pathologic | 1 | 2018 | 55 | 0.160 |
Why?
| | Blood Proteins | 1 | 2020 | 231 | 0.150 |
Why?
| | Severity of Illness Index | 5 | 2019 | 2540 | 0.150 |
Why?
| | Cattle | 2 | 2019 | 920 | 0.150 |
Why?
| | Ebstein Anomaly | 1 | 2018 | 6 | 0.150 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2019 | 102 | 0.150 |
Why?
| | Arterial Pressure | 1 | 2019 | 99 | 0.150 |
Why?
| | Colorado | 3 | 2020 | 4100 | 0.150 |
Why?
| | Tricuspid Valve Insufficiency | 1 | 2018 | 19 | 0.150 |
Why?
| | Turner Syndrome | 1 | 2018 | 44 | 0.150 |
Why?
| | Dyspnea | 1 | 2020 | 211 | 0.150 |
Why?
| | Incidence | 2 | 2022 | 2313 | 0.150 |
Why?
| | Risk Assessment | 4 | 2011 | 2968 | 0.150 |
Why?
| | Prosthesis Design | 1 | 2019 | 285 | 0.140 |
Why?
| | Constriction, Pathologic | 2 | 2012 | 208 | 0.140 |
Why?
| | Cohort Studies | 3 | 2021 | 4895 | 0.140 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2021 | 685 | 0.140 |
Why?
| | Prosthesis-Related Infections | 1 | 2017 | 70 | 0.140 |
Why?
| | Bradycardia | 1 | 2017 | 48 | 0.140 |
Why?
| | Williams Syndrome | 2 | 2009 | 15 | 0.140 |
Why?
| | Patient Selection | 2 | 2015 | 641 | 0.140 |
Why?
| | Prevalence | 2 | 2020 | 2251 | 0.140 |
Why?
| | Ultrasonography, Prenatal | 2 | 2018 | 236 | 0.130 |
Why?
| | Fetal Diseases | 1 | 2017 | 147 | 0.130 |
Why?
| | Nitric Oxide | 1 | 2021 | 823 | 0.130 |
Why?
| | Tracheal Stenosis | 1 | 2016 | 24 | 0.130 |
Why?
| | Energy Metabolism | 1 | 2021 | 731 | 0.130 |
Why?
| | Myocytes, Cardiac | 1 | 2019 | 449 | 0.130 |
Why?
| | Survival Rate | 4 | 2013 | 1644 | 0.120 |
Why?
| | Equipment Failure | 1 | 2015 | 106 | 0.120 |
Why?
| | Heart Block | 1 | 2014 | 38 | 0.120 |
Why?
| | Cardiac Catheterization | 5 | 2022 | 534 | 0.120 |
Why?
| | Glycogen Storage Disease | 1 | 2014 | 20 | 0.110 |
Why?
| | Calcium | 1 | 2019 | 1108 | 0.110 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 916 | 0.110 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2014 | 50 | 0.110 |
Why?
| | Myocardial Ischemia | 1 | 2014 | 235 | 0.110 |
Why?
| | Anastomosis, Surgical | 3 | 2021 | 136 | 0.100 |
Why?
| | Matrix Metalloproteinase 7 | 2 | 2023 | 25 | 0.100 |
Why?
| | Respiratory Insufficiency | 1 | 2015 | 290 | 0.100 |
Why?
| | Suture Techniques | 1 | 2012 | 115 | 0.100 |
Why?
| | Transplantation, Homologous | 2 | 2010 | 377 | 0.090 |
Why?
| | Lung | 2 | 2014 | 3561 | 0.090 |
Why?
| | Principal Component Analysis | 2 | 2023 | 175 | 0.090 |
Why?
| | Vascular Resistance | 2 | 2019 | 337 | 0.090 |
Why?
| | Rare Diseases | 1 | 2011 | 89 | 0.090 |
Why?
| | Angiography | 1 | 2011 | 174 | 0.090 |
Why?
| | Air Ambulances | 1 | 2010 | 34 | 0.080 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 493 | 0.080 |
Why?
| | Adaptive Immunity | 1 | 2010 | 155 | 0.080 |
Why?
| | Primary Graft Dysfunction | 1 | 2009 | 30 | 0.080 |
Why?
| | Sternotomy | 2 | 2022 | 18 | 0.080 |
Why?
| | Travel | 1 | 2010 | 121 | 0.080 |
Why?
| | Lung Diseases, Interstitial | 1 | 2014 | 508 | 0.080 |
Why?
| | Craniofacial Abnormalities | 1 | 2009 | 59 | 0.080 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 4624 | 0.080 |
Why?
| | Granuloma, Plasma Cell | 1 | 2008 | 12 | 0.080 |
Why?
| | Coronary Vessel Anomalies | 1 | 2008 | 30 | 0.070 |
Why?
| | Prosthesis Implantation | 1 | 2009 | 138 | 0.070 |
Why?
| | Mitral Valve Insufficiency | 1 | 2008 | 63 | 0.070 |
Why?
| | Probability | 1 | 2008 | 289 | 0.070 |
Why?
| | Lung Diseases | 1 | 2013 | 701 | 0.070 |
Why?
| | Patient Readmission | 1 | 2012 | 610 | 0.070 |
Why?
| | Biomarkers | 3 | 2023 | 3408 | 0.070 |
Why?
| | Waiting Lists | 2 | 2022 | 211 | 0.070 |
Why?
| | Proteomics | 2 | 2023 | 836 | 0.070 |
Why?
| | Hemodilution | 1 | 2006 | 10 | 0.070 |
Why?
| | Imaging, Three-Dimensional | 2 | 2020 | 512 | 0.070 |
Why?
| | Blood Transfusion, Autologous | 1 | 2006 | 19 | 0.070 |
Why?
| | Double Outlet Right Ventricle | 1 | 2006 | 9 | 0.070 |
Why?
| | Survivors | 1 | 2009 | 411 | 0.060 |
Why?
| | Combined Modality Therapy | 1 | 2008 | 1121 | 0.060 |
Why?
| | Blood Pressure | 2 | 2019 | 1538 | 0.060 |
Why?
| | Hypoxia | 2 | 2022 | 958 | 0.060 |
Why?
| | Middle Aged | 4 | 2019 | 26738 | 0.060 |
Why?
| | Adult | 4 | 2019 | 30553 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2020 | 3252 | 0.060 |
Why?
| | Stents | 2 | 2009 | 475 | 0.060 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2023 | 25 | 0.060 |
Why?
| | Birth Weight | 1 | 2006 | 440 | 0.050 |
Why?
| | Blood Coagulation Disorders | 1 | 2006 | 197 | 0.050 |
Why?
| | Constriction | 1 | 2003 | 45 | 0.050 |
Why?
| | Extracellular Matrix | 2 | 2023 | 436 | 0.050 |
Why?
| | Polytetrafluoroethylene | 1 | 2003 | 25 | 0.050 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2023 | 133 | 0.050 |
Why?
| | Myocardium | 2 | 2023 | 913 | 0.050 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 127 | 0.050 |
Why?
| | Salvage Therapy | 1 | 2003 | 127 | 0.050 |
Why?
| | Multiple Organ Failure | 2 | 2013 | 146 | 0.050 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 18 | 0.050 |
Why?
| | Acrocephalosyndactylia | 1 | 2021 | 10 | 0.050 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2022 | 190 | 0.050 |
Why?
| | Postoperative Period | 1 | 2022 | 289 | 0.050 |
Why?
| | Animals | 3 | 2019 | 31709 | 0.050 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 2021 | 33 | 0.050 |
Why?
| | Preoperative Period | 1 | 2020 | 103 | 0.040 |
Why?
| | Diabetic Cardiomyopathies | 1 | 2020 | 34 | 0.040 |
Why?
| | Patient-Specific Modeling | 1 | 2020 | 36 | 0.040 |
Why?
| | Electrophysiological Phenomena | 1 | 2019 | 48 | 0.040 |
Why?
| | Pulmonary Veins | 1 | 2020 | 81 | 0.040 |
Why?
| | Cartilage | 1 | 2021 | 182 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2021 | 641 | 0.040 |
Why?
| | Software | 1 | 2023 | 530 | 0.040 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 80 | 0.040 |
Why?
| | Autografts | 1 | 2019 | 40 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2020 | 347 | 0.040 |
Why?
| | Serotonin | 1 | 2020 | 292 | 0.040 |
Why?
| | Tricuspid Valve | 1 | 2018 | 25 | 0.040 |
Why?
| | Logistic Models | 2 | 2014 | 1841 | 0.040 |
Why?
| | Shear Strength | 1 | 2018 | 65 | 0.040 |
Why?
| | Recovery of Function | 2 | 2013 | 574 | 0.040 |
Why?
| | Echocardiography, Three-Dimensional | 1 | 2018 | 48 | 0.040 |
Why?
| | Pulse Wave Analysis | 1 | 2018 | 207 | 0.040 |
Why?
| | Mass Spectrometry | 1 | 2020 | 633 | 0.040 |
Why?
| | Pregnancy | 2 | 2018 | 5520 | 0.030 |
Why?
| | Length of Stay | 2 | 2012 | 962 | 0.030 |
Why?
| | Metabolomics | 1 | 2020 | 521 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2019 | 695 | 0.030 |
Why?
| | Phosphorylation | 1 | 2019 | 1569 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2022 | 2765 | 0.030 |
Why?
| | Hospital Mortality | 2 | 2012 | 776 | 0.030 |
Why?
| | Catheters | 1 | 2015 | 63 | 0.030 |
Why?
| | Aniridia | 1 | 2014 | 5 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1320 | 0.030 |
Why?
| | Oxygen | 1 | 2018 | 854 | 0.030 |
Why?
| | Bronchoscopy | 1 | 2016 | 245 | 0.030 |
Why?
| | Tachycardia | 1 | 2014 | 50 | 0.030 |
Why?
| | Airway Obstruction | 1 | 2016 | 168 | 0.030 |
Why?
| | Aortic Valve Insufficiency | 1 | 2013 | 45 | 0.030 |
Why?
| | Compassionate Use Trials | 1 | 2013 | 8 | 0.030 |
Why?
| | Hyperbilirubinemia | 1 | 2013 | 14 | 0.030 |
Why?
| | Thoracotomy | 1 | 2013 | 75 | 0.030 |
Why?
| | Spirometry | 1 | 2013 | 224 | 0.030 |
Why?
| | Vital Capacity | 1 | 2013 | 255 | 0.030 |
Why?
| | Body Size | 1 | 2013 | 92 | 0.030 |
Why?
| | Forced Expiratory Volume | 1 | 2013 | 475 | 0.020 |
Why?
| | Acute Disease | 1 | 2014 | 911 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2019 | 3886 | 0.020 |
Why?
| | Equipment Design | 1 | 2013 | 508 | 0.020 |
Why?
| | Mortality | 1 | 2013 | 287 | 0.020 |
Why?
| | Cause of Death | 1 | 2013 | 361 | 0.020 |
Why?
| | Organ Size | 1 | 2012 | 436 | 0.020 |
Why?
| | Liver Diseases | 1 | 2013 | 255 | 0.020 |
Why?
| | Risk | 1 | 2013 | 812 | 0.020 |
Why?
| | France | 1 | 2010 | 34 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2013 | 1075 | 0.020 |
Why?
| | Registries | 1 | 2017 | 1768 | 0.020 |
Why?
| | Shock, Cardiogenic | 1 | 2010 | 53 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2013 | 1342 | 0.020 |
Why?
| | Kidney Diseases | 1 | 2013 | 350 | 0.020 |
Why?
| | Internationality | 1 | 2010 | 143 | 0.020 |
Why?
| | Tricuspid Atresia | 1 | 2008 | 6 | 0.020 |
Why?
| | Venae Cavae | 1 | 2008 | 9 | 0.020 |
Why?
| | Hemorrhage | 1 | 2013 | 620 | 0.020 |
Why?
| | Device Removal | 1 | 2009 | 126 | 0.020 |
Why?
| | Comorbidity | 1 | 2013 | 1448 | 0.020 |
Why?
| | Syndrome | 1 | 2009 | 333 | 0.020 |
Why?
| | United States | 2 | 2017 | 12186 | 0.020 |
Why?
| | Angioplasty, Balloon | 1 | 2009 | 88 | 0.020 |
Why?
| | Sampling Studies | 1 | 2008 | 93 | 0.020 |
Why?
| | Aortography | 1 | 2008 | 50 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 4410 | 0.020 |
Why?
| | Vascular Patency | 1 | 2008 | 97 | 0.020 |
Why?
| | Echocardiography, Doppler | 1 | 2008 | 92 | 0.020 |
Why?
| | Prothrombin Time | 1 | 2006 | 34 | 0.020 |
Why?
| | Platelet Count | 1 | 2006 | 81 | 0.020 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2006 | 171 | 0.020 |
Why?
| | Fibrinogen | 1 | 2006 | 154 | 0.020 |
Why?
| | Ultrasonography | 1 | 2008 | 634 | 0.010 |
Why?
| | Heparin | 1 | 2006 | 224 | 0.010 |
Why?
| | Terminology as Topic | 1 | 2006 | 187 | 0.010 |
Why?
| | Ephrin-B2 | 1 | 2004 | 36 | 0.010 |
Why?
| | Stroke | 1 | 2013 | 1022 | 0.010 |
Why?
| | Cricetinae | 1 | 2004 | 253 | 0.010 |
Why?
| | Transplantation, Autologous | 1 | 2004 | 176 | 0.010 |
Why?
| | Anticoagulants | 1 | 2006 | 550 | 0.010 |
Why?
| | Aged | 1 | 2019 | 19074 | 0.010 |
Why?
| | Recurrence | 1 | 2004 | 935 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2004 | 1264 | 0.010 |
Why?
|
|
Mitchell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|